Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benicar and Benicar HCT in Stage II Systolic Hypertension
NCT00185068Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of olmesartan in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Change in mean trough seated systolic blood pressure. Started Mar 2004; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00185068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185068.